Lam Research (LRCX) to Post Q3 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2258614/lam-research-lrcx-to-post-q3-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258614
Apr 19, 2024 - Lam Research's (LRCX) third-quarter fiscal 2024 results are expected to reflect strength in 3D DRAM and advanced packaging amid a slowdown in memory spending.
0
Netflix ETFs to Buy on the Dip Post Solid Q1 Earnings
https://www.zacks.com/stock/news/2258499/netflix-etfs-to-buy-on-the-dip-post-solid-q1-earnings?cid=CS-ZC-FT-etf_news_and_commentary-2258499
Apr 19, 2024 - Netflix (NFLX) topped both earnings and revenue estimates and delivered its strongest first-quarter customer additions since the pandemic. However, it issued disappointing second-quarter revenue guidance, which dragged the stock down.
0
Otis Worldwide (OTIS) to Post Q1 Earnings: Factors to Note
https://www.zacks.com/stock/news/2259541/otis-worldwide-otis-to-post-q1-earnings-factors-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259541
Apr 22, 2024 - Otis Worldwide's (OTIS) first-quarter 2024 performance is likely to have benefited from strong volume and favorable pricing. Yet, currency fluctuations are a concern.
0
Rockwell Automation (ROK) to Post Q2 Earnings: What's in Store?
https://www.zacks.com/stock/news/2259409/rockwell-automation-rok-to-post-q2-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2259409
Apr 22, 2024 - Rockwell Automation's (ROK) second-quarter fiscal 2024 performance is likely to reflect the impact of the ongoing supply-chain issues and elevated costs.
0
Eastman Chemical (EMN) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2260537/eastman-chemical-emn-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2260537
Apr 23, 2024 - Eastman's (EMN) cost-cutting initiatives and innovation are anticipated to have benefited the company in Q1.
0
Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
https://www.zacks.com/stock/news/2260461/corcept-cort-posts-positive-data-from-cushing-s-syndrome-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2260461
Apr 23, 2024 - Corcept (CORT) reports positive data from the open-label portion of the phase III GRACE study evaluating relacorilant for treating patients with Cushing's syndrome.
0
Trane Technologies (TT) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2261559/trane-technologies-tt-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2261559
Apr 24, 2024 - Trane Technologies' (TT) first-quarter 2024 earnings and revenues are likely to increase year over year.
0
Zebra Technologies (ZBRA) to Post Q1 Earnings: What to Expect
https://www.zacks.com/stock/news/2263545/zebra-technologies-zbra-to-post-q1-earnings-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263545
Apr 26, 2024 - Weakness in the Asset Intelligence & Tracking and Enterprise Visibility & Mobility segments are likely to have hurt Zebra Technologies' (ZBRA) first-quarter performance.
0
IPG Photonics (IPGP) to Post Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2263443/ipg-photonics-ipgp-to-post-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263443
Apr 26, 2024 - IPG Photonics' (IPGP) first-quarter 2024 results are likely to suffer from weakness in cutting and marking applications and sluggish demand in China market.
0
Iron Mountain (IRM) to Post Q1 Earnings: What's in Store?
https://www.zacks.com/stock/news/2264419/iron-mountain-irm-to-post-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264419
Apr 29, 2024 - Strength in core storage and record management businesses and solid data center demand are likely to have aided Iron Mountain's (IRM) Q1 earnings. However, high interest expenses remain a concern.
0